Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II carfilzomib-cyclophosphamide-dexamethasone induction and high-dose melphalan with or without carfilzomib-dexamethasone maintenance in relapsed multiple myeloma
2013-003789-15Phase 2Completed
- Sponsor
- Nordic Myeloma Study Group
- Start
- Dec 2013
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in multiple myeloma (MM) comparing Observation after salvage HDT/ASCT with Carfilzomib + dexamethasone maintenance (2 arms). Started Dec 2013; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2013-003789-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003789-15.